Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page
- Check5 days agoChange DetectedThe header revision tag was updated from v3.6.4 to v3.6.5, signaling a newer build of the page. This is a metadata-level change and does not modify the study information presented.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry, v3.6.4, has been added to replace the previous v3.6.3 in the page's revision history, indicating an updated version of the page. The update does not alter the study details or visible information.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.6.3 has replaced the previous Revision: v3.6.2 on the page, indicating a platform update.SummaryDifference0.0%

- Check48 days agoChange DetectedA new publication entry is added to Publications detailing a three-year Lebrikizumab extension study with author names; the page revision is updated to v3.6.2, replacing the prior v3.6.0.SummaryDifference0.0%

- Check62 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', signaling that the study is closed to new participants, and several help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). Publications references were updated by adding a 2026 Lebrikizumab study citation and removing the older 2025 citation, and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s Revision tag changed from v3.5.4 to v3.5.5, indicating a new build of the page. This appears to reflect a behind-the-scenes update rather than a substantive change to the study information.SummaryDifference0.0%

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.